Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
15.13
-0.01 (-0.03%)
At close: Jun 16, 2026, 4:00 PM EDT
15.14
+0.02 (0.10%)
After-hours: Jun 16, 2026, 5:26 PM EDT

Surgery Partners Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Surgery Partners stock has a consensus rating of "Buy" and an average price target of $17.95. The average 1-year stock price forecast is 18.68% higher than the current stock price, while the lowest is $14 (-7.44%) and the highest is $24 (+58.68%).

Price Target: $17.95 (+18.68%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$14$17.95$17.5$24
Change-7.44%+18.68%+15.70%+58.68%

Analyst Ratings

The average analyst rating for Surgery Partners stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingNov '25Dec '25Mar '26Apr '26May '26Jun '26
Strong Buy888888
Buy111111
Hold333333
Sell000000
Strong Sell000000
Total121212121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Maintains
$13$17
BuyMaintains$13$17+12.40%May 27, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$18
BuyMaintains$18+15.70%May 14, 2026
RBC Capital
RBC Capital
Buy
Maintains
$20
BuyMaintains$20+32.23%May 13, 2026
Barclays
Barclays
Hold
Reiterates
$14
HoldReiterates$14-7.44%May 13, 2026
KeyBanc
KeyBanc
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.41B
from 3.31B
Increased by 3.01%
Revenue Next Year
3.59B
from 3.41B
Increased by 5.27%
EPS This Year
0.45
from 0.47
Decreased by -4.92%
EPS Next Year
0.65
from 0.45
Increased by 46.40%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.23B2.54B2.74B3.11B3.31B3.41B
Revenue Growth
19.62%14.12%8.03%13.52%6.24%3.01%
Gross Profit
491.40M574.90M647.50M745.60M765.00M799.27M
Gross Margin
22.08%22.64%23.60%23.94%23.12%23.45%
Operating Income
304.10M376.90M416.00M474.30M479.50M388.55M
Net Income
-70.90M-54.60M-11.90M-168.10M-77.90M-33.47M
EPS
----0.470.45
EPS Growth
-----49.46%-4.92%
Forward PE
183.8658.7135.0823.3124.9333.85
Free Cash Flow
21.04M17.25M143.38M192.28M164.71M334.00M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.4B
Avg3.4B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
3.5%
Avg
3.0%
Low
2.4%

EPS Forecast

EPS202620272028
High0.69
Avg0.45
Low0.27

EPS Growth

EPS Growth202620272028
High
46.8%
Avg
-4.9%
Low
-42.6%